From the Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany.

Corresponding author: Thomas Kohnen, MD, PhD, FEBO, Department of Ophthalmology, Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany. Email: [email protected].

Presented at the ESCRS Meeting, Vienna, Austria, September 2023, and at the DOG Meeting, Berlin, Germany, September 2023.

Disclosures: T. Kohnen: consultant and research for Abbott Medical Optics/Johnson & Johnson Vision, Alcon Laboratories, Inc./Novartis Corp., Avedro, Inc., Oculentis GmbH, Oculus Optikgeräte GmbH, Presbia Coöperatief U.A., Santen GmbH, Schwind eye-tech-solutions GmbH & Co. KG, Carl Zeiss Meditec AG; consultant for Allergan, Inc., Bausch & Lomb, Inc., Dompé, Geuder AG, Med Update, Merck Frosst Canada Ltd., Rayner Intraocular Lenses Ltd., STAAR Surgical Co., Théa Pharma GmbH, TearLab Corp., Thieme Compliance GmbH, and Ziemer Ophthalmology GmbH; and research for Avedro, Inc. and Hoya Surgical Optics GmbH. None of the other authors have any financial or proprietary interest in any material or method mentioned.

First author:Petra Davidova, MDDepartment of Ophthalmology, Goethe-University, Frankfurt am Main, Germany